Altorki N - Search Results

1

Characterization of cell lines established from human gastric-esophageal adenocarcinomas. Biologic phenotype and invasion potential.

Altorki N, Schwartz GK, Blundell M, Davis BM, Kelsen DP, Albino AP. Altorki N, et al. Cancer. 1993 Aug 1;72(3):649-57. doi: 10.1002/1097-0142(19930801)72:3<649::aid-cncr2820720305>3.0.co;2-l. Cancer. 1993. PMID: 8334620

2

Infrequent point mutations of ras oncogenes in gastric cancers.

Nanus DM, Kelsen DP, Mentle IR, Altorki N, Albino AP. Nanus DM, et al. Among authors: altorki n. Gastroenterology. 1990 Apr;98(4):955-60. doi: 10.1016/0016-5085(90)90019-w. Gastroenterology. 1990. PMID: 2179035 Free article.

3

11p13-15 is a specific region of chromosomal rearrangement in gastric and esophageal adenocarcinomas.

Rodriguez E, Rao PH, Ladanyi M, Altorki N, Albino AP, Kelsen DP, Jhanwar SC, Chaganti RS. Rodriguez E, et al. Among authors: altorki n. Cancer Res. 1990 Oct 1;50(19):6410-6. Cancer Res. 1990. PMID: 2400998

4

Esophageal carcinoma with airway invasion. Evolution and choices of therapy.

Altorki NK, Migliore M, Skinner DB. Altorki NK, et al. Chest. 1994 Sep;106(3):742-5. doi: 10.1378/chest.106.3.742. Chest. 1994. PMID: 7521814

5

The mutational status of p53 protein in gastric and esophageal adenocarcinoma cell lines predicts sensitivity to chemotherapeutic agents.

Nabeya Y, Loganzo F Jr, Maslak P, Lai L, de Oliveira AR, Schwartz GK, Blundell ML, Altorki NK, Kelsen DP, Albino AP. Nabeya Y, et al. Among authors: altorki nk. Int J Cancer. 1995 Feb 20;64(1):37-46. doi: 10.1002/ijc.2910640109. Int J Cancer. 1995. PMID: 7665247

6

Amplification of HER-2/neu gene in human gastric adenocarcinomas: correlation with primary site.

Albino AP, Jaehne J, Altorki N, Blundell M, Urmacher C, Lauwers G, Niedzwiecki D, Kelsen DP. Albino AP, et al. Among authors: altorki n. Eur J Surg Oncol. 1995 Feb;21(1):56-60. doi: 10.1016/s0748-7983(05)80069-1. Eur J Surg Oncol. 1995. PMID: 7851555

7

Defining the invasive phenotype of proximal gastric cancer cells.

Schwartz GK, Wang H, Lampen N, Altorki N, Kelsen D, Albino AP. Schwartz GK, et al. Among authors: altorki n. Cancer. 1994 Jan 1;73(1):22-7. doi: 10.1002/1097-0142(19940101)73:1<22::aid-cncr2820730106>3.0.co;2-o. Cancer. 1994. PMID: 8275429

8

Expression of acidic fibroblast growth factor in Barrett's esophagus and associated esophageal adenocarcinoma.

Soslow RA, Ying L, Altorki NK. Soslow RA, et al. Among authors: altorki nk. J Thorac Cardiovasc Surg. 1997 Nov;114(5):838-43. doi: 10.1016/S0022-5223(97)70089-8. J Thorac Cardiovasc Surg. 1997. PMID: 9375615 Free article.

9

En bloc esophagectomy improves survival for stage III esophageal cancer.

Altorki NK, Girardi L, Skinner DB. Altorki NK, et al. J Thorac Cardiovasc Surg. 1997 Dec;114(6):948-55; discussion 955-6. doi: 10.1016/S0022-5223(97)70009-6. J Thorac Cardiovasc Surg. 1997. PMID: 9434690 Free article.

10

Human lung cancer antigens recognized by autologous antibodies: definition of a novel cDNA derived from the tumor suppressor gene locus on chromosome 3p21.3.

Güre AO, Altorki NK, Stockert E, Scanlan MJ, Old LJ, Chen YT. Güre AO, et al. Among authors: altorki nk. Cancer Res. 1998 Mar 1;58(5):1034-41. Cancer Res. 1998. PMID: 9500467

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

390 results

Search Page

Filters